Skip to main content

and
  1. Article

    Open Access

    Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside

    Immunotherapy has rapidly evolved in the past decades in the battle against cancer. Chimeric antigen receptor (CAR)-engineered T cells have demonstrated significant success in certain hematologic malignancies,...

    Beibei Zhang, Mengzhe Yang, Weiming Zhang, Ning Liu, Daogang Wang in Cell Death & Disease (2024)